NO20030201L - Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner - Google Patents

Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Info

Publication number
NO20030201L
NO20030201L NO20030201A NO20030201A NO20030201L NO 20030201 L NO20030201 L NO 20030201L NO 20030201 A NO20030201 A NO 20030201A NO 20030201 A NO20030201 A NO 20030201A NO 20030201 L NO20030201 L NO 20030201L
Authority
NO
Norway
Prior art keywords
treatment
viral infections
receptor antagonists
exacerbation
directed
Prior art date
Application number
NO20030201A
Other languages
English (en)
Norwegian (no)
Other versions
NO20030201D0 (no
Inventor
Susan B Dillon
Ruth Talsinger
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20030201D0 publication Critical patent/NO20030201D0/no
Publication of NO20030201L publication Critical patent/NO20030201L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030201A 2000-07-18 2003-01-15 Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner NO20030201L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21905300P 2000-07-18 2000-07-18
PCT/US2001/022328 WO2002005814A1 (en) 2000-07-18 2001-07-16 Use of il-8 receptor antagonists in the treatment of virus infections

Publications (2)

Publication Number Publication Date
NO20030201D0 NO20030201D0 (no) 2003-01-15
NO20030201L true NO20030201L (no) 2003-03-17

Family

ID=22817645

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030201A NO20030201L (no) 2000-07-18 2003-01-15 Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner

Country Status (17)

Country Link
EP (1) EP1307190A4 (es)
JP (1) JP2004509852A (es)
KR (1) KR20030019587A (es)
CN (1) CN1449285A (es)
AR (1) AR033830A1 (es)
AU (1) AU2001273497A1 (es)
BR (1) BR0112603A (es)
CA (1) CA2418162A1 (es)
CZ (1) CZ2003132A3 (es)
HU (1) HUP0300754A3 (es)
IL (1) IL153921A0 (es)
MX (1) MXPA03000500A (es)
NO (1) NO20030201L (es)
NZ (1) NZ523659A (es)
PL (1) PL365886A1 (es)
WO (1) WO2002005814A1 (es)
ZA (1) ZA200300474B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008509143A (ja) * 2004-08-04 2008-03-27 シェーリング コーポレイション 気道疾患の処置のためのプレコナリルを含む薬学的処方物
PE20170185A1 (es) * 2014-05-12 2017-04-01 Glaxosmithkline Intellectual Property (No 2) Ltd Composiciones farmaceuticas para tratar enfermedades infecciosas
BR112022018294A2 (pt) * 2020-03-26 2023-01-10 Dompe Farm Spa Inibidores de cxcl8 para uso no tratamento de covid-19
EP3884932A1 (en) * 2020-03-26 2021-09-29 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19
EP4008325A1 (en) * 2020-12-02 2022-06-08 Dompe' Farmaceutici S.P.A. Cxcl8 inhibitors for use in the treatment of covid-19

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5547979A (en) * 1992-03-30 1996-08-20 Smithkline Beecham TNF inhibition
WO1996005836A2 (en) * 1994-08-25 1996-02-29 Medical University Of South Carolina Methods of treating cold symptoms using pentoxifylline
JPH11503110A (ja) * 1995-02-17 1999-03-23 スミスクライン・ビーチャム・コーポレイション Ｉｌ−８受容体拮抗剤
SE9802729D0 (sv) * 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
SE9802937D0 (sv) * 1998-09-01 1998-09-01 Astra Pharma Prod Novel compounds

Also Published As

Publication number Publication date
KR20030019587A (ko) 2003-03-06
CZ2003132A3 (cs) 2003-09-17
ZA200300474B (en) 2004-08-17
WO2002005814A1 (en) 2002-01-24
AU2001273497A1 (en) 2002-01-30
BR0112603A (pt) 2004-08-24
HUP0300754A3 (en) 2009-03-02
PL365886A1 (en) 2005-01-10
NZ523659A (en) 2006-01-27
MXPA03000500A (es) 2003-06-24
JP2004509852A (ja) 2004-04-02
NO20030201D0 (no) 2003-01-15
EP1307190A1 (en) 2003-05-07
IL153921A0 (en) 2003-07-31
HUP0300754A2 (hu) 2003-08-28
CN1449285A (zh) 2003-10-15
EP1307190A4 (en) 2007-08-22
CA2418162A1 (en) 2002-01-24
AR033830A1 (es) 2004-01-07

Similar Documents

Publication Publication Date Title
HUP0400719A2 (hu) Vegyületek és eljárások Chlamydia-fertőzés diagnosztikájára és kezelésére
FR16C0028I2 (fr) Vecteurs viraux et utilisation de ces derniers dans des methodes therapeutiques
FR16C1012I2 (fr) Utilisation therapeutique d'anticorps anti-cs1
EA200300628A1 (ru) Соединения, специфические к аденозиновому a, aи aрецептору, и их применение
DE50312299D1 (de) Inhalationstherapievorrichtung
TR200000913T2 (tr) Tıbbi maddeler
MA30128B1 (fr) Combinaisons pharmaceutiques d'un antagoniste de receptuer d'angiotensine et d'un inhibiteur de nep
TR200102021T2 (tr) TWEAK ve TWEAK reseptörü antagonistleri ve bunların imünolojik bozuklukların iyileştirilmesi için kullanımları
ATE425253T1 (de) Tribonektine
DK1327143T3 (da) Krystalstruktur af BACE og anvendelse deraf
ID29095A (id) Antagonis mglur5 untuk pengobatan rasa sakit dan kegelisahan
ATE419845T1 (de) Il-8-rezeptor-antagonisten
TR200502508T2 (tr) IL-18 İnhibitörlerinin kullanımı.
HUP0101719A2 (hu) Javított immundiagnosztikai vizsgálati eljárások redukáló ágensek alkalmazásával
IS2259B (is) Aðferð til meðferðar á netjuhersli með notkun mótlyfs við integríninu alfa-4 undireiningunni
EA200400399A1 (ru) Способы лечения легочных заболеваний
NO20030201L (no) Bruk av IL-8 reseptorantagonister ved behandling av virusinfeksjoner
DE60101559D1 (de) Benutzung von comt-inhibitoren als analgetika
YU68602A (sh) Monoklonska antitela na humani ldl receptor, njihova produkcija i korišćenje
DK1421377T3 (da) Naturlig ligand for den orphane G-proteinkoblede receptor GPR86 og metoder til anvendelse
TR200103448T2 (tr) IL-8 reseptör antagonistleri.
TR200002939T2 (tr) Paroksetin maleat
PT1448566E (pt) Antagonistas do receptor quimioquina e metodos de utilizacao do mesmo
DE60113535D1 (de) Kompositionen und verwendungen von cgi-69
FR3097738B1 (fr) Inhibiteurs de l'entree capacitive du calcium

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application